These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance. Wardle EN; Menon IS; Anderson J Q J Med; 1972 Jan; 41(161):15-23. PubMed ID: 5070986 [No Abstract] [Full Text] [Related]
8. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure. Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms and treatment of dyslipidemia of renal diseases. Toto RD; Vega GL; Grundy SM Curr Opin Nephrol Hypertens; 1993 Sep; 2(5):784-90. PubMed ID: 7922219 [TBL] [Abstract][Full Text] [Related]
10. [Hyperlipidemia in rats with chronic renal failure]. Nikiforova NV; Tananaeva IK; Pozdniakov AL; Sokolovskaia IV Biull Eksp Biol Med; 1978 Jun; 85(6):676-9. PubMed ID: 208685 [TBL] [Abstract][Full Text] [Related]
11. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia. Rahman M; Salamatullah Q; Ferdous Z; Hussain MA Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998 [TBL] [Abstract][Full Text] [Related]
12. Serum lipids in renal insufficiency. Heuck CC; Ritz E; Liersch M; Mehls O Am J Clin Nutr; 1978 Sep; 31(9):1547-53. PubMed ID: 210650 [No Abstract] [Full Text] [Related]
13. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis. Cattran DC; Steiner G; Fenton SS; Wilson DR Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333 [No Abstract] [Full Text] [Related]
14. Serumlipoproteins in children with nephrotic syndrome and chronic renal failure. Widhalm K; Singer P; Balzar E Artery; 1980; 8(2):191-8. PubMed ID: 7458686 [No Abstract] [Full Text] [Related]
15. [Changes in serum lipoproteins in kidney diseases]. Mordasini R; Riesen W Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693 [TBL] [Abstract][Full Text] [Related]
16. [Concentration of various serum lipids and its clinical significance]. Kameoka M; Ueda S; Hirata M; Okazaki S; Ishida S Rinsho Byori; 1969 Aug; 17(8):610-4. PubMed ID: 5391166 [No Abstract] [Full Text] [Related]
17. [Incidence and classification of hyperlipidemias]. Hartmann G Helv Med Acta Suppl; 1967 May; 47():123. PubMed ID: 5286294 [No Abstract] [Full Text] [Related]
18. [The effect of adresone and alimentary sucrose loading on blood lipids and beta-lipoprotein composition]. Khegaĭ MD; Zharova IP Vopr Pitan; 1972; 31(4):63-6. PubMed ID: 4644440 [No Abstract] [Full Text] [Related]
19. Plasma lipid patterns in chronic renal failure. Lamberth EL; Oates JA Trans Am Soc Artif Intern Organs; 1975; 21():473-8. PubMed ID: 1146020 [TBL] [Abstract][Full Text] [Related]
20. [Hyperlipidemia and hyperinsulinemia in kidney diseases occurring with the nephrotic syndrome]. Razboinikov S; Tishkov I; Shipkova P; Turkolov N; Mushmov D Urol Nefrol (Mosk); 1979; (4):19-23. PubMed ID: 473433 [No Abstract] [Full Text] [Related] [Next] [New Search]